From immunohistochemistry to new digital ecosystems: a state-of-the-art biomarker review for precision breast cancer medicine

SM Hacking, E Yakirevich, Y Wang - Cancers, 2022 - mdpi.com
Simple Summary In this state-of-the-art breast biomarker review, we have tried to imagine
and illustrate future, emerging digital breast cancer ecosystems which allow for greater …

Emerging biomarkers in breast cancer care

R Napieralski, N Brünner, K Mengele… - Biomarkers in …, 2010 - Taylor & Francis
Currently, decision-making for breast cancer treatment in the clinical setting is mainly based
on clinical data, histomorphological features of the tumor tissue and a few cancer …

Biomarker studies in early detection and prognosis of breast cancer

G Li, J Hu, G Hu - Translational Research in Breast Cancer: Biomarker …, 2017 - Springer
Breast cancer is characterized with enormous heterogeneity, which represents the major
hurdle for accurate diagnosis and curative therapy. It is generally believed that genome …

Classic and new markers in diagnostics and classification of breast cancer

R Beňačka, D Szabóová, Z Guľašová, Z Hertelyová… - Cancers, 2022 - mdpi.com
Simple Summary With ever-increasing incidence, breast cancer is considered a most
diagnosed type of cancer among women worldwide. Breast cancer arises through malignant …

Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics

S Girotra, K Yeghiazaryan… - Personalized Medicine, 2016 - Taylor & Francis
Breast cancer (BC) prevalence has reached an epidemic scale with half a million deaths
annually. Current deficits in BC management include predictive and preventive approaches …

diagnosis and treatment of breast cancer in 2022: the rise of novel molecular biomarkers

N Fusco, U Malapelle, C Criscitiello - Frontiers in Molecular …, 2023 - frontiersin.org
We are experiencing an amazing era of advances in the diagnosis and treatment of breast
cancer, with the discovery of novel actionable biomarkers (eg, programmed deathligand 1 …

[HTML][HTML] The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine

FB De Abreu, WA Wells, GJ Tsongalis - The American journal of pathology, 2013 - Elsevier
Breast cancer is a complex disease characterized by many morphological, clinical, and
molecular features. For many years, breast cancer has been classified according to …

[PDF][PDF] Diagnostic, prognostic, and predictive biomarkers in breast cancer

CJ Li, HM Chen, JC Lai - Journal of Oncology, 2020 - scienceopen.com
Breast cancer is the most frequently diagnosed cancer type and the second leading cause of
cancer-related deaths among women worldwide. The causes of breast cancer are not yet …

'Omics approaches in breast cancer research and clinical practice

P Kalita-de Croft, F Al-Ejeh, AEMC Reed… - Advances in …, 2016 - journals.lww.com
Our understanding of the natural history of breast cancer has evolved alongside
technologies to study its genomic, transcriptomic, proteomic, and metabolomics landscapes …

Advances in the molecular analysis of breast cancer: pathway toward personalized medicine

M Rosa - Cancer Control, 2015 - journals.sagepub.com
Background Breast cancer is a heterogeneous disease that encompasses a wide range of
clinical behaviors and histological and molecular variants. It is the most common type of …